H2S prevents the disruption of the blood-brain barrier in rats with prenatal hyperhomocysteinemia

• Published in: Journal of pharmacological sciences 2024-08, Vol.155 (4), p.131-139
• Main Authors: Yakovlev, A.V., Detterer, A.S., Yakovleva, O.V., Hermann, A., Sitdikova, G.F.
• Format: Article
• Language: English
• Subjects: Blood-brain barrier; Hydrogen sulfide; Inflammation; Nitrites; Prenatal hyperhomocysteinemia
• ISSN: 1347-8613; 1347-8648
• DOI: 10.1016/j.jphs.2024.05.001

Elevation of the homocysteine concentration in the plasma called hyperhomocysteinemia (hHCY) during pregnancy causes a number of pre- and postnatal developmental disorders. The aim of our study was to analyze the effects of H2S donors –NaHS and N-acetylcysteine (NAC) on blood-brain barrier (BBB) permeability in rats with prenatal hHCY. In rats with mild hHCY BBB permeability assessed by Evans Blue extravasation in brain increased markedly throughout life. Administration of NaHS or NAC during pregnancy attenuated hHCY-associated damage and increased endogenous concentrations of sulfides in brain tissues. Acute application of dl-homocysteine thiolactone induced BBB leakage, which was prevented by the NMDA receptor antagonist MK-801 or H2S donors. Rats with hHCY demonstrated high levels of NO metabolite – nitrites and proinflammatory cytokines (IL-1β, TNF-α, IL-6) in brain. Lactate dehydrogenase (LDH) activity in the serum was higher in rats with hHCY. Mitochondrial complex-I activity was lower in brain of hHCY rats. NaHS treatment during pregnancy restored levels of proinflammatory cytokines, nitrites and activity of the respiratory chain complex in brain as well as the LDH activity in serum. Our data suggest that H2S has neuroprotective effects against prenatal hHCY-associated BBB disturbance providing a potential strategy for the prevention of developmental impairments in newborns.